Display options
Share it on

Oncol Lett. 2016 Jan;11(1):798-800. doi: 10.3892/ol.2015.3934. Epub 2015 Nov 17.

Acquired amegakaryocytic thrombocytopenic purpura induced by percutaneous ethanol injection during treatment of hepatocellular carcinoma: A case report.

Oncology letters

Ding-Lun Ai, Bo-Tao Li, Xiao-Ming Peng, Lin-Zhi Zhang, Jing-Yan Wang, Yun Zhao, Bin Yang, Qiang Yu, Chun-Zi Liu, Ning Yang, Hua-Ming Wang, Lin Zhou

Affiliations

  1. Department of Interventional Radiology, Beijing 302nd Hospital, Beijing 100039, P.R. China.
  2. Department of Hematopoietic Stem Cell Transplantation, Affiliated Hospital to the Chinese Academy of Military Medical Sciences, Beijing 100071, P.R. China.
  3. Department of Clinical Laboratory, Beijing 302nd Hospital, Beijing 100039, P.R. China.

PMID: 26870287 PMCID: PMC4727072 DOI: 10.3892/ol.2015.3934

Abstract

Percutaneous ethanol injection is an important localized treatment method for patients presenting with hepatocellular carcinoma (HCC). Among the advantages of percutaneous ethanol injection are its minimal invasiveness, simplicity, low cost and low risk of complications. However, the increasing popularity of percutaneous ethanol injection has resulted in serious adverse effects attributed to individual variations. The present study describes the case of a patient who exhibited acquired amegakaryocytic thrombocytopenic purpura, caused by percutaneous ethanol injection treatment for HCC. This complication was promptly identified, and platelet transfusion and injection of recombinant human interleukin-11 resulted in a rapid recovery of the patient's platelet count. Attention should be given to this rare complication in patients administered percutaneous ethanol injection treatment for HCC.

Keywords: acquired amegakaryocytic thrombocytopenic purpura; complication; hepatocellular carcinoma; percutaneous ethanol injection

References

  1. Gan To Kagaku Ryoho. 1989 Sep;16(9):3311-8 - PubMed
  2. Radiology. 1995 Oct;197(1):101-8 - PubMed
  3. Transplant Proc. 2005 Nov;37(9):3871-3 - PubMed
  4. Br J Haematol. 1986 Feb;62(2):333-44 - PubMed
  5. Blood. 1997 Nov 15;90(10):3893-902 - PubMed
  6. Cancer. 2007 May 1;109(9):1705-14 - PubMed
  7. J Ultrasound Med. 1998 Aug;17 (8):531-3 - PubMed
  8. Alcohol Clin Exp Res. 2004 Apr;28(4):619-24 - PubMed
  9. Cancer. 1998 Jul 1;83(1):48-57 - PubMed
  10. Arch Intern Med. 1980 May;140(5):721-3 - PubMed
  11. Minerva Med. 2009 Feb;100(1):51-68 - PubMed
  12. World J Gastroenterol. 2007 Feb 21;13(7):1003-9 - PubMed
  13. Eur J Intern Med. 2005 Nov;16(7):477-81 - PubMed
  14. Leuk Res. 2008 May;32(5):823-7 - PubMed
  15. Cochrane Database Syst Rev. 2015 Jan 26;1:CD006745 - PubMed
  16. Liver Int. 2012 Oct;32(9):1434-42 - PubMed
  17. CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90 - PubMed
  18. Eur J Haematol. 2002 Sep;69(3):185-6 - PubMed
  19. Cancer. 2003 Jun 15;97(12):3099-106 - PubMed
  20. J Lab Clin Med. 1992 Nov;120(5):699-706 - PubMed

Publication Types